16 Nov rare disease clinical trials: Being informed about clinical research
A mother's personal journey to find a clinical trial for her child's rare disease and how she navigated through the challenges. ...
News
15 Nov Doctors: Vaccinating children fills vital gap in COVID-19 vaccine landscape
Posted at 16:17h
in COVID-19
The recent approval of a COVID-19 vaccine for children ages 5 to 11 years old opens the possibility of vaccinating the last large remaining segment of the population, according to doctors. ...
12 Nov UW–Madison responds to federal COVID-19 vaccination mandate
Posted at 16:23h
in COVID-19
On Sept. 9, President Biden issued an executive order requiring COVID-19 vaccination for all federal contractors. UW–Madison currently holds federal contracts. In order to comply with the broad scope of the order, all employees must provide proof of vaccination or receive a medical or religious accommodation exempting them...
08 Nov Moderna COVID-19 vaccine pediatric clinical trial to focus on ages 6 months to 5 years
The KidCOVE phase three clinical trial at the University of Wisconsin School of Medicine and Public Health, which is evaluating the safety and effectiveness of the Moderna COVID-19 vaccine in children, has shifted focus to kids 6 months to 5-years-old. In August, enrollment for kids...
05 Nov University of Wisconsin Center for Rare Diseases recognized by National Organization for Rare Disorders
Posted at 18:02h
in Clinical Research
The University of Wisconsin Center for Rare Diseases has been selected as a National Organization for Rare Disorders (NORD) Rare Disease Center of Excellence. UW–Madison School of Medicine and Public Health The UW Center for Rare Diseases, a new joint collaboration between the Division of Genetics and Metabolism...
29 Oct Confused about whether to get a booster? Health experts share what they’re telling friends and family
Posted at 16:52h
in COVID-19
It's the question on many Americans' minds: Should I get a booster shot? And if so, when's the best time?...
06 Oct Decentralized trials can overcome the challenges of rare disease patients
Posted at 19:34h
in Uncategorized
By Ed Miseta, Clinical Leader There are 400 million people worldwide who are impacted by more than 7,000 identifiable rare diseases. While individual rare diseases are uncommon, approximately 5% of the world’s population suffers from one. For many of those patients, travelling to a clinic to...
18 Sep Nasia Safdar named inaugural associate dean for clinical trials
Nasia Safdar, MD, PhD, has been named the University of Wisconsin School of Medicine and Public Health's inaugural associate dean for clinical trials and the research director of the new Wisconsin Medicine Institute for Clinical Trials, a joint venture between the school and UW Health. UW–Madison...
14 Sep Equity in psychedelic therapies
UW researchers are leading a new two-year study, funded by a grant from the Wisconsin Alumni Research Foundation (WARF), to increase representation in clinical studies....
31 Aug FDA releases their first public Notice of Noncompliance to a Principal Investigator
Posted at 16:07h
in CT.gov
The first public notice of noncompliance was sent out to a Principal Investigator at an Academic Medical Center....